Ilaris is a human monoclonal antibody that precisely targets and neutralizes interleukin one beta, a pro-inflammatory cytokine in the body. Canakinumab is marketed under the trade name Ilaris and is used to treat anti-inflammatory illnesses and reduce inflammation.

Ilaris commonly prescribed to treat following diseases:

• Cryopyrin-associated periodic syndrome
• Systemic Juvenile Idiopathic Arthritis (SJIA)
• Periodic syndrome associated with the receptor for tumor necrosis factor (TRAPS)
• Still’s disease treatment

• Allergy
• Headache
• Infections of the upper respiratory tract
• Vomiting or abdominal pain
• Nausea
• A skin rash
• Elevated liver enzyme levels
• A low amount of white blood cells